Posted on 10/27/2021 4:31:35 PM PDT by BenLurkin
The drug, which costs roughly 29p per tablet, was trialled on nearly 741 people who tested positive within seven days and had underlying health conditions.
Patients were given a daily course of two pills for 10 days. Of those given the medication, 79 (10.6 per cent) needed hospital care compared to 15.7 per cent in the placebo group.
Writing in the paper, the researchers said their analysis showed the pills cut the risk of hospitalisation by 32 per cent.
Fluvoxamine works by boosting the amount of serotonin in the brain, which can help to boost someone's mood.
But the hormone is also involved in regulating the immune system, and can help prevent it from overreacting and attacking healthy cells, which can be fatal.
Professor Penny Ward, a pharmaceutical physician at King's College London who was not involved in the research said: 'Fluvoxamine was identified as a possible treatment for covid based on its effects (as an antiviral) and impact on platelet function (reducing risk of inflammation).'
(Excerpt) Read more at dailymail.co.uk ...
I don’t think it is unreasonable to suspect my VA doctor doesn’t know diddly-squat about monoclonals, lol.
Have you tried to order any over the counter drugs through the mail lately, good luck with that.
Doesn’t Ivermectin reduce the risk by over two-thirds?
Most Treatable flu, is the covid.
How does someone decide to test an antidepressant for reducing Covid hospitalizations?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.